MEK inhibitor trang 1 tải miễn phí từ TAILIEUCHUNG

"MEK inhibitor" trang 1 - tải miễn phí từ Tailieuchung

The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway

13 37 1

Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro

11 33 1

Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901

11 45 1

Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy

12 43 1

Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma

14 54 0

A dose-dependent response to MEK inhibition determines hypoblast fate in bovine embryos

13 11 1

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

21 8 1

Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care

12 28 1

Comparative efficacy and safety of combination therapies for advanced melanoma: A network meta-analysis

10 36 1

$A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01$

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

9 41 0

Granulomatosis with polyangiitis in a patient treated with dabrafenib and trametinib for BRAF V600E positive lung adenocarcinoma

5 75 0

$Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-IMETRY): Protocol for a multicentre UK single arm phase II trial$

Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-IMETRY): Protocol for a multicentre UK single arm phase II trial

10 80 0

Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression

10 46 1

Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

12 25 1

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

7 48 1